Comments

Dermata Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Dermata Therapeutics (DRMAW) operate in?

Dermata Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

DRMAWNASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

Dermata Therapeutics (DRMAW) Forecast

News Earnings Dermata Therapeutics (DRMAW) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Dermata Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:DRMAW | Benzinga

Explore Dermata Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for DRMAW.

Open	-
Close	-
Volume / Avg.	0 / 13.41K
Day Range	- - -
52 Wk Range	0.01 - 0.04
Market Cap	-
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	-
Days to Cover	1.66

Recent News

Why Dermata Therapeutics Stock Took Off After-Hours

Dermata Therapeutics, Inc.

Ryan Gustafson

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Open	-
Close	-
Volume / Avg.	0 / 13.41K
Day Range	- - -
52 Wk Range	0.01 - 0.04
Market Cap	-
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	0
Short Interest	-
Days to Cover	1.66

About Dermata Therapeutics Inc

Sector

Health Care

Industry

Biotechnology

Dermata Therapeutics Inc is a late-stage medical dermatology company focused on identifying, develop...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Dermata Therapeutics (DRMAW) stock?

You can purchase shares of Dermata Therapeutics (NASDAQ:DRMAW) through any online brokerage.

View our list of the best stock brokerages

Who are Dermata Therapeutics (DRMAW) competitors?

Other companies in Dermata Therapeutics’s space includes: BeiGene (NASDAQ:ONC), Exact Sciences (NASDAQ:EXAS), Neurocrine Biosciences (NASDAQ:NBIX), Roivant Sciences (NASDAQ:ROIV) and Amgen (NASDAQ:AMGN).

What is the forecast, or price target, for Dermata Therapeutics (DRMAW) stock?

There is no analysis for Dermata Therapeutics to provide a consensus price target.

What is the current price for Dermata Therapeutics (DRMAW)?

The stock price for Dermata Therapeutics (NASDAQ: DRMAW) is $0.0137 last updated May 20, 2025 at 10:26 AM EDT.

Does Dermata Therapeutics (DRMAW) pay a dividend?

There are no upcoming dividends for Dermata Therapeutics.

When is Dermata Therapeutics (NASDAQ:DRMAW) reporting earnings?

Dermata Therapeutics does not have any upcoming earnings scheduled.

Is Dermata Therapeutics (DRMAW) going to split?

There is no upcoming split for Dermata Therapeutics.

What sector and industry does Dermata Therapeutics (DRMAW) operate in?

Dermata Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.